Article
Functional genomics reveals that tumors with activating phosphoinositide 3-kinase mutations are dependent on accelerated protein turnover.
Genes & development - 15 Dec 2016
Davoli Teresa, Mengwasser Kristen E, Duan Jingjing, Chen Ting, Christensen Camilla, Wooten Eric C, Anselmo Anthony N, Li Mamie Z, Wong Kwok-Kin, Kahle Kristopher T, Elledge Stephen J
Abstract excerpt
Activating mutations in the phosphoinositide 3-kinase (PI3K) signaling pathway are frequently identified in cancer. To identify pathways that support PI3K oncogenesis, we performed a genome-wide RNAi screen in isogenic cell lines harboring wild-type or mutant PIK3CA to search for PI3K synthetic-lethal (SL) genes. A combined analysis of these results with a meta-analysis of two other large-scale RNAi screening...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
